Tranzyme Completes Drug Discovery Collaboration With Bristol-Myers Squibb

Tranzyme Pharma (NASDAQ: TZYM ) today announced the successful completion of its chemistry-based drug discovery collaboration with Bristol-Myers Squibb (NYSE: BMY ). As a result of the joint research efforts, Tranzyme has transferred compounds to Bristol-Myers Squibb for further development across multiple drug targets. As part of this